Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FirstMedicare Direct was a branded Medicare Advantage offering associated with FirstCarolinaCare, serving Medicare beneficiaries in North Carolina through HMO, HMO-POS, and PPO plan designs. It operated as a health insurance brand rather than a drug-development biotech or pharmaceutical company, with products focused on medical and prescription coverage for Medicare-eligible members. Publicly available plan materials identify FirstCarolinaCare Insurance Company as the insurer behind certain FirstMedicare Direct plans. In 2025, parent-affiliated organizations announced that FirstMedicare Direct would stop offering Medicare Advantage coverage effective January 1, 2026, with coverage ending December 31, 2025. As a result, the entity appears to be an inactive insurance brand rather than an operating life sciences company with an R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FirstMedicare Direct.